Literature DB >> 33527223

Participation of Monocarboxylate Transporter 8, But Not P-Glycoprotein, in Carrier-Mediated Cerebral Elimination of Phenytoin across the Blood-Brain Barrier.

Ryuta Jomura1, Shin-Ichi Akanuma2,3, Björn Bauer4, Yukiko Yoshida1, Yoshiyuki Kubo1, Ken-Ichi Hosoya1.   

Abstract

PURPOSE: In this study, we investigated in detail the transport of phenytoin across the blood-brain barrier (BBB) to identify the transporter(s) involved in BBB-mediated phenytoin efflux from the brain.
METHODS: We evaluated the brain-to-blood efflux transport of phenytoin in vivo by determining the brain efflux index (BEI) and uptake in brain slices. We additionally conducted brain perfusion experiments and BEI studies in P-glycoprotein (P-gp)-deficient mice. In addition, we determined the mRNA expression of monocarboxylate transporter (MCT) in isolated brain capillaries and performed phenytoin uptake studies in MCT-expressing Xenopus oocytes.
RESULTS: [14C]Phenytoin brain efflux was time-dependent with a half-life of 17 min in rats and 31 min in mice. Intracerebral pre-administration of unlabeled phenytoin attenuated BBB-mediated phenytoin efflux transport, suggesting carrier-mediated phenytoin efflux transport across the BBB. Pre-administration of P-gp substrates in rats and genetic P-gp deficiency in mice did not affect BBB-mediated phenytoin efflux transport. In contrast, pre-administration of MCT8 inhibitors attenuated phenytoin efflux. Moreover, rat MCT8-expressing Xenopus oocytes exhibited [14C]phenytoin uptake, which was inhibited by unlabeled phenytoin.
CONCLUSION: Our data suggest that MCT8 at the BBB participates in phenytoin efflux transport from the brain to the blood.

Entities:  

Keywords:  MCT8; P-glycoprotein; blood-brain barrier; monocarboxylate transporter; phenytoin

Mesh:

Substances:

Year:  2021        PMID: 33527223      PMCID: PMC8906351          DOI: 10.1007/s11095-021-03003-1

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  40 in total

1.  Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite.

Authors:  M Bajpai; L K Roskos; D D Shen; R H Levy
Journal:  Drug Metab Dispos       Date:  1996-12       Impact factor: 3.922

2.  In vivo evidence for P-glycoprotein-mediated transport of phenytoin at the blood-brain barrier of rats.

Authors:  H Potschka; W Löscher
Journal:  Epilepsia       Date:  2001-10       Impact factor: 5.864

3.  Early identification of refractory epilepsy.

Authors:  P Kwan; M J Brodie
Journal:  N Engl J Med       Date:  2000-02-03       Impact factor: 91.245

4.  P-Glycoprotein mediates the efflux of quinidine across the blood-brain barrier.

Authors:  H Kusuhara; H Suzuki; T Terasaki; A Kakee; M Lemaire; Y Sugiyama
Journal:  J Pharmacol Exp Ther       Date:  1997-11       Impact factor: 4.030

5.  Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter.

Authors:  Edith C H Friesema; Sumita Ganguly; Amal Abdalla; Jocelyn E Manning Fox; Andrew P Halestrap; Theo J Visser
Journal:  J Biol Chem       Date:  2003-07-18       Impact factor: 5.157

6.  Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone.

Authors:  Takashi Okura; Asami Hattori; Yusuke Takano; Takenori Sato; Margareta Hammarlund-Udenaes; Tetsuya Terasaki; Yoshiharu Deguchi
Journal:  Drug Metab Dispos       Date:  2008-07-07       Impact factor: 3.922

7.  Oxymorphone active uptake at the blood-brain barrier and population modeling of its pharmacokinetic-pharmacodynamic relationship.

Authors:  Muhammad Waqas Sadiq; Emma Boström; Ron Keizer; Sven Björkman; Margareta Hammarlund-Udenaes
Journal:  J Pharm Sci       Date:  2013-03-05       Impact factor: 3.534

8.  Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis.

Authors:  Steffen Mayerl; Julia Müller; Reinhard Bauer; Sarah Richert; Celia M Kassmann; Veerle M Darras; Katrin Buder; Anita Boelen; Theo J Visser; Heike Heuer
Journal:  J Clin Invest       Date:  2014-04-01       Impact factor: 14.808

9.  Associations between single nucleotide polymorphisms in thyroid hormone transporter genes (MCT8, MCT10 and OATP1C1) and circulating thyroid hormones.

Authors:  Greet L Roef; Ernst R Rietzschel; Tim De Meyer; Sofie Bekaert; Marc L De Buyzere; Caroline Van daele; Kaatje Toye; Jean-Marc Kaufman; Youri E Taes
Journal:  Clin Chim Acta       Date:  2013-08-24       Impact factor: 3.786

Review 10.  Neurosteroid Transport in the Brain: Role of ABC and SLC Transporters.

Authors:  Markus Grube; Paul Hagen; Gabriele Jedlitschky
Journal:  Front Pharmacol       Date:  2018-04-11       Impact factor: 5.810

View more
  3 in total

Review 1.  A Historical Review of Brain Drug Delivery.

Authors:  William M Pardridge
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

Review 2.  Monocarboxylate Transporter 8 Deficiency: From Pathophysiological Understanding to Therapy Development.

Authors:  Ferdy S van Geest; Nilhan Gunhanlar; Stefan Groeneweg; W Edward Visser
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-01       Impact factor: 5.555

3.  An Atlas of the Quantitative Protein Expression of Anti-Epileptic-Drug Transporters, Metabolizing Enzymes and Tight Junctions at the Blood-Brain Barrier in Epileptic Patients.

Authors:  Risa Sato; Kotaro Ohmori; Mina Umetsu; Masaki Takao; Mitsutoshi Tano; Gerald Grant; Brenda Porter; Anthony Bet; Tetsuya Terasaki; Yasuo Uchida
Journal:  Pharmaceutics       Date:  2021-12-09       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.